Cancer Genomics Conference The Molecular Landscape of Melanoma. 2025-2026 - 6/24/2025

---

RSSCMECNE

Tuesday, June 24, 2025, 8:00 AM - 9:00 AM

Cancer Genomics Conference is a multidisciplinary conference held monthly with a didactic and open discussion focused on the molecular drivers of cancers. This joint conference between Hematology/Oncology and Pathology helps our teams understand the principles of genomic testing of cancer and how these results are interpreted and used for patient management. This conference provides a forum to learn and discuss challenging and interesting aspects of cancer genomics.

Objective(s):
Location:
Specialties: DERMATOLOGY, CLINICAL GENETICS AND GENOMICS (MD), INTERNAL MEDICINE - Hematology, INTERVENTIONAL RADIOLOGY AND DIAGNOSTIC RADIOLOGY, INTERNAL MEDICINE - Medical Oncology, PATHOLOGY - CLINICAL, RADIATION ONCOLOGY, SURGERY, THORACIC AND CARDIAC SURGERY, PATHOLOGY-ANATOMIC/PATHOLOGY-CLINICAL

Faculty Disclosures:
Michael Christensen, MD (Nothing to disclose - 06/09/2025)
Download Handout

In support of improving patient care, Penn Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.  

Designation of Credit
Physicians: Penn Medicine designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AMA PRA Category 1 Credits™ (1.00 hours), NCPD Hours (ANCC) (1.00 hours), Non-Physician Attendance / Participation (1.00 hours)

Mitigation of Relevant Financial Relationships

Penn Medicine adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Date	Empty Column	Title
		No activities are currently published for this month.
No upcoming dates have been setup.